Piper Sandler Maintains Neutral on Elanco Animal Health, Lowers Price Target to $15

Piper Sandler analyst David Westenberg maintains Elanco Animal Health (NYSE:ELAN) with a Neutral and lowers the price target from $21 to $15.

Piper Sandler analyst David Westenberg maintains Elanco Animal Health (NYSE:ELAN) with a Neutral and lowers the price target from $21 to $15.

Total
0
Shares
Related Posts